BioCentury
ARTICLE | Company News

Drug Royalty acquires FluMist royalties

July 11, 2007 1:18 AM UTC

Drug Royalty (Toronto, Ontario) acquired the University of Michigan's future royalties on sales of FluMist intranasal influenza vaccine for up to $35 million. FluMist posted $36 million in sales last ...